ZCM
UTHR icon

Ziegler Capital Management’s United Therapeutics UTHR Stock Holding History

Ziegler Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$541K Sell
6,857
-1,013
-13% -$74K 0.05% 285
2013
Q2 		$518K Buy
+7,870
New +$507K 0.06% 299

Other funds holding UTHR

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ziegler Capital Management's UTHR Position: Q3 2013 in Review

Ziegler Capital Management reduced its United Therapeutics (UTHR) stake by 13% in Q3 2013, selling an estimated $74K and leaving 6,857 shares worth $541K. The position accounts for 0.05% of the portfolio, ranked #285.

Ziegler Capital Management first reported a position in UTHR in Q2 2013 and has held it in 2 quarters since. 293 funds tracked by Wall St. Rank hold UTHR as of Q3 2013.

  • Ziegler Capital Management held 6,857 shares of United Therapeutics worth $541K as of Q3 2013.
  • Ziegler Capital Management sold 1,013 United Therapeutics shares in Q3 2013, an estimated $74K.
  • United Therapeutics made up 0.05% of Ziegler Capital Management's portfolio in Q3 2013, its #285 holding.
  • Ziegler Capital Management first reported a position in United Therapeutics in Q2 2013 and has held it in 2 quarters since.
  • 293 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2013.

Based on Ziegler Capital Management's 13F filing for Q3 2013, filed 6 Nov 2013.